SI-Bone announces big plans for its newly raised $33 million | Medtech funding stories for the week of Apr. 28, 2014

SI-Bone has big plans for newly raised $33M

April 30, 2014 by Arezu Sarvestani

San Jose, Calif.-based SI-Bone has big plans for its newly raised $33 million, saying it’ll use the new funds to add additional resources and chase regulatory approvals overseas for its iFuse bone fixation system.

Financing came from new investors Orbimed and Novo A/S, as well as from existing funders Skyline Ventures and Montreux Equity Partners, SI-Bone reported. Read more

Stryker readies $1B debt offering

April 29, 2014 by Brad Perriello

Stryker said it’s planning to float $1 billion worth of senior notes as it refinances its debt load.

The Kalamazoo, Mich.-based medical device company said it’s pricing 2 sets of senior unsecured notes: $600 million, at 3.38% annually, due in May 2024; and $400 million, at 4.38%, due in May 2044. Read more

Funding: Sequana raises $26.2M for implantable bladder pump

April 28, 2014 by Arezu Sarvestani

Switzerland-based medtech company Sequana Medical has big plans for its newly-closed $26.2 million (CHF 23 million) Series C financing round, hoping to use the funds to widen its global sales and begin penetrating the U.S. market.

The company hopes to launch U.S. clinical trials of its alfapump device, a fully implantable bladder pump that continuously removes excess abdominal fluid in patients suffering from liver disease. The device won CE Mark approval in 2011 to sell in the European Union, and Sequana is looking to expand its commercial efforts globally, CEO Noel Johnson said in prepared remarks. Read more